Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Share Price    (AUBD)

Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Before 11:59pm TONIGHT: Get Our Most Important Research for Just Rs 2950 295

REFRESH
Live BSE Quotes Oct 30, 2020 (Close)
Price (Rs)772.75 Open (Rs) 769.50 High (Rs) 778.05 Low (Rs) 761.25
% Change0.52 Volume 100,674 Value (Rs) 77,511,699 52-Week H/L 967.60 / 281.15
Live NSE Quotes Oct 30, 2020 (Close)
Price (Rs)772.65 Open (Rs) 768.35 High (Rs) 778.40 Low (Rs) 761.10
% Change0.65 Volume 2,036,809 Value (Rs) 1,569,233,616 52-Week H/L 967.50 / 288.85
Change
1 Day
0.52%
1 Month
-2.99%
3 Months
-5.79%
1 Year
66.92%
5 Years (CAGR)*
-1.54%
10 Years (CAGR)*
20.02%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 51.38 P/E Ratio (x) 15.04 Market Cap (Rs m) 452,189.34 P/BV (x) 3.26
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AUROBINDO PHARMA Share Price Today:

AUROBINDO PHARMA last traded price was up 0.5% to Rs 772.8 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was up 0.7% to Rs 772.7. The total volume of shares traded was 2.1 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.0%. And the benchmark S&P BSE SENSEX was at 39,614.1 (down 0.3%).

Over the last 30 days, the AUROBINDO PHARMA share price is down 3.0%. And over the last one year, AUROBINDO PHARMA share price is up 63.8%.



What else is happening in the markets today? Dig in...


Today's Market

Sensex Ends 136 Points Lower; Telecom and Automobile Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

One Cycle that Defines Everything in Markets (Profit Hunter)

Oct 23, 2020

Know this cycle to boost your profits in the market.

Markets are Always Right? (The Honest Truth)

Oct 30, 2020

Ajit Dayal on why you shouldn't let your guard down as an investor.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS